Felicitex Therapeutics | Press Release

"Developing novel treatments for Dormant Cancers - targeting resistance, metastasis, and relapse."

March 30, 2019

Felicitex to present at Annual AACR Meeting in Atlanta on April 2nd, 2019

March 25, 2017

Felicitex to present at Annual AACR Meeting in Washington DC on April 1nd, 2017.

January 8, 2016

Felicitex to present at 8th Annual BioTech Showcase in San Fransisco on January 11th, 2016

July 20, 2015

Emerging Company Profile - BioCentury on BioBusiness

June 24, 2015

Massachusetts Grant Provides $200,000 Non-dilutive Funding to Felicitex Therapeutics

May 19, 2015

Felicitex Therapeutics and Diaxonhit Announce Global Exclusive License of a Series of Lead-stage Anti-cancer Compounds from Diaxonhit for the Development of Therapeutics against Quiescent Cancer Cells

November 7, 2014

Felicitex Therapeutics and Selvita Initiate Strategic Collaboration to Target Cancer Quiescence

© 2019 by Felicitex Therapeutics, Inc »« 27 Strathmore Road Natick, MA 01760 1-919-213-0025 (p) Click here to Contact Us!